Skip to main content

Table 1 Patient profiles

From: Autologous glioma cell vaccine admixed with interleukin-4 gene transfected fibroblasts in the treatment of patients with malignant gliomas

95-033      
Case # Age Gender Tumor # of previous recurrence Vaccine/Adverse events
1 63 Male Lt. Temporal GBM 2 Yes/Grade 2 skin reaction
2 60 Male Lt. Temporal AA 3 Yes/Grade 1 skin reaction
3 40 Male Rt. Frontal GBM 3 No due to tumor progression
4 57 Male Lt. Parieto/Occi GBM 1 No due to tumor progression
5 32 Female Lt. Parieto/Occi GBM 1 No due to tumor progression
6 53 Female Rt. Frontal GBM 2 No due to tumor progression
99-111      
Case # Age Gender Tumor TTP (Months) Vaccine/Adverse events
1 56 Male Lt. Parietal GBM 4 Yes/Grade 1 headache
2 66 Male Rt. Frontal GBM N/A No due to tumor progression
3 45 Male Lt. Temporal GBM 10 Yes/None
4 53 Male Lt. Occipital GBM 6 Yes/None
5 50 Male Rt. Frontal GBM 6 Yes/None
6 61 Female Rt. Temporal GBM 4 Yes/None
  1. TTP: Time To Progression